Yes, I know I'm talking to myself, but I do have a vested interest in the Novavax story.
Assuming there are no changes of heart/plan or sudden switch to Trial.2 - the Novavax next generation cocktail mix or something similar - apparently the trial will be unblinded once the final UK efficacy data is released and the placebo group will then be offered Novavax. I hope it's true, I've developed a strange commitment to the product by being part of the trial and I'd be disappointed not to get it
One of the regional trial leads is quoted as saying:
“When we are given the green light we will start to ‘unblind’ the trial and we will see which participants have received the vaccine. Those who received the placebo will now be asked back to receive two doses of the Novavax vaccine 21 days apart. This means that all those who took part on the trial will ultimately have protection against this deadly virus.”
https://www.thetelegraphandargus.co...ors-pride-leading-trial-covid-19-jab-novavax/
Which is in itself is a reminder of how complicated current/future clinical trial will be. I suspect from this point on vaccine v placebo (particularly in the over 50s or high risk groups) will have to stop and be replaced with vaccine v other vaccine versions.